GE HealthCare Technologies (GEHC) Shares Outstanding (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Shares Outstanding (Entity) came in at $459.5 million in Q2 2026, little changed YoY from $458.3 million in Q2 2025, and little changed on a QoQ basis from $459.4 million in Q1 2026.
GE HealthCare Technologies (GEHC) Shares Outstanding (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Shares Outstanding (Entity) data on file, last reported at $459.5 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) changed 0.26% year-over-year to $459.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $459.5 million (changed 0.26% YoY) and the FY2025 annual result came in at $458.8 million, changed 0.35% from the prior year.
- Shares Outstanding (Entity) held at $459.5 million in Q2 2026, from $459.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $459.5 million in Q2 2026 to a low of $454.0 million in Q1 2022.
- A 5-year average of $456.5 million and a median of $456.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) increased 0.14% — and 2024, when it gained 0.42%.
- Tracing GEHC's Shares Outstanding (Entity) over 5 years: stood at $454.0 million in 2022, then grew by 0.3% to $455.3 million in 2023, then increased by 0.42% to $457.2 million in 2024, then advanced by 0.35% to $458.8 million in 2025, then rose by 0.14% to $459.5 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $459.5 million (Q2 2026), $459.4 million (Q1 2026), and $458.8 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 192.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 453.00 Mn |
| Mar 31, 2026 | 456.00 Mn |
| Dec 31, 2025 | 456.00 Mn |
| Sep 30, 2025 | 456.00 Mn |
| Jun 30, 2025 | 457.00 Mn |
| Mar 31, 2025 | 457.00 Mn |
| Dec 31, 2024 | 456.00 Mn |
| Sep 30, 2024 | 457.00 Mn |
| Jun 30, 2024 | 457.00 Mn |
| Mar 31, 2024 | 456.00 Mn |
| Dec 31, 2023 | 455.00 Mn |
| Sep 30, 2023 | 455.00 Mn |
| Jun 30, 2023 | 455.00 Mn |
| Mar 31, 2023 | 454.00 Mn |
| Dec 31, 2022 | 454.00 Mn |
| Sep 30, 2022 | 454.00 Mn |
| Jun 30, 2022 | 454.00 Mn |
| Mar 31, 2022 | 454.00 Mn |